4th Jun 2018 11:15
LONDON (Alliance News) - Silence Therapeutics PLC on Monday announced the departure of Chief Executive Ali Mortazavi with immediate effect after six years in the job.
He will be replaced as Chairman Annalisa Jenkins on an interim basis while Silence looks for a new Chief Executive Officer.
Jenkins commented: "On behalf of the board I would like to thank Ali for his achievements and commitment to Silence over the past six years. Under his leadership Silence has built an experienced international executive team with significant RNAi expertise that has established a strong IP and technology platform in GalNAC-based siRNA.
"We believe today that our RNAi platform and R&D capabilities offer an opportunity to advance our lead programme in iron metabolism towards the clinic and to establish research partnerships that will maximise shareholder value. We wish Ali every success in his future endeavours."
Shares were 8.9% higher on Monday at a price of 147.00 pence each.
Related Shares:
SLN.L